Healthcare Capital Corp set to open at 4-month high on $1 bln deal with Alpha Tau
** Blank check co's HCCC.O shares up 2.6% at $9.89
premarket, set to open at about 4-month high
** SPAC to take Israeli oncology therapeutics co Alpha Tau
Medical Ltd public in $1 bln deal urn:newsml:reuters.com:*:nPn1m92Vza
** Alpha Tau to be listed on Nasdaq post merger - companies
** Founded in 2016, the company focuses on research and
development of technology for treatment of tumors
** Deal to be financed through $275 mln in cash from HCCC
and $92 mln PIPE (private investment in public equity) funding
** Citigroup advised Alpha and Cantor Fitzgerald advised the
SPAC on the deal
(Reporting by Niket Nishant in Bengaluru)
((Niket.Nishant@thomsonreuters.com;))
Recent news on Alpha Tau Medical
See all newsBrief: Alpha Tau Completes Patient Enrollment In Its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal Of FDA Approval Of Alpha Dart® To Treat Recurrent Cutaneous Squamous Cell Carcinoma
Brief: Alpha Tau Announces 100% Local Disease Control Rate And Favorable Safety Profile Observed In Alpha Dart® Pancreatic Cancer Trials Presented At Ddw 2026
Brief: Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing
Brief: Alpha Tau Announces First-Ever Oral Presentation Of Alpha Dart® Pancreatic Cancer Data At Digestive Disease Week (Ddw) 2026
Brief: Alpha Tau Medical Receives Japanese Marketing Approval For Alpha Dart In Head And Neck Cancer